Zions Bancorporation, N.A. Nuvasive Inc Transaction History

Zions Bancorporation, N.A.

$1.36 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$36.81 - $48.12 $502,971 - $657,511	-13,664 Reduced 99.69%	43 $1,000
Q4 2022 Feb 10, 2023	SELL	$35.68 - $44.71 $13,629 - $17,079	-382 Reduced 2.71%	13,707 $565,000
Q3 2022 Nov 08, 2022	SELL	$42.51 - $54.02 $212 - $270	-5 Reduced 0.04%	14,089 $617,000
Q2 2022 Aug 05, 2022	BUY	$46.84 - $59.75 $126,468 - $161,325	2,700 Added 23.7%	14,094 $693,000
Q1 2022 May 13, 2022	BUY	$48.09 - $57.79 $145,856 - $175,277	3,033 Added 36.28%	11,394 $646,000
Q4 2021 Feb 11, 2022	BUY	$47.19 - $62.68 $61,913 - $82,236	1,312 Added 18.61%	8,361 $439,000
Q3 2021 Nov 10, 2021	BUY	$56.91 - $67.81 $40,918 - $48,755	719 Added 11.36%	7,049 $422,000
Q2 2021 Aug 11, 2021	BUY	$64.02 - $71.72 $54,545 - $61,105	852 Added 15.55%	6,330 $429,000
Q1 2021 May 13, 2021	BUY	$53.26 - $68.08 $63,645 - $81,355	1,195 Added 27.9%	5,478 $359,000
Q4 2020 Feb 12, 2021	BUY	$43.41 - $56.51 $8,247 - $10,736	190 Added 4.64%	4,283 $241,000
Q3 2020 Nov 13, 2020	BUY	$47.43 - $60.75 $12,616 - $16,159	266 Added 6.95%	4,093 $199,000
Q2 2020 Aug 13, 2020	BUY	$43.51 - $66.59 $14,793 - $22,640	340 Added 9.75%	3,827 $213,000
Q1 2020 May 15, 2020	BUY	$32.82 - $81.13 $27,897 - $68,960	850 Added 32.23%	3,487 $177,000
Q4 2019 Feb 14, 2020	SELL	$60.96 - $77.7 $40,355 - $51,437	-662 Reduced 20.07%	2,637 $204,000
Q3 2019 Nov 13, 2019	BUY	$55.78 - $68.08 $1,059 - $1,293	19 Added 0.58%	3,299 $209,000
Q2 2019 Jul 09, 2019	BUY	$53.69 - $65.47 $10,201 - $12,439	190 Added 6.15%	3,280 $192,000
Q1 2019 May 10, 2019	BUY	$44.53 - $58.9 $137,597 - $182,001	3,090 New	3,090 $175,000

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account